Lancet Infectious Diseases

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world's best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823-present
Impact factor
33.633 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Diseases, Conditions, Syndromes

Universal guideline for treating mucormycosis developed

Professor Oliver Cornely, head of the European Centre of Excellence for Invasive Fungal Infections at Cologne University Hospital, has developed a globally applicable diagnosis and treatment guideline for the rare disease ...

Medical research

A weapon to make a superbug become even more deadly

A recent research led by a scientist at City University of Hong Kong (CityU) has discovered an easily transmitted DNA piece that can make a new type of hyper-resistant and deadly superbug become hyper-virulent quickly, posing ...